The claimEvidence A · guideline-tier
Milk thistle pills protect the liver, lower enzymes, and repair liver damage
The evidence
Poor absorption plus rapid phase II conjugation means almost no free compound reaches hepatocytes; Cochrane pooling found no effect on mortality or complications, and SyNCH at 3-5x customary dose was no better than placebo.
Why the claim spreads
It is the world's best-selling liver herb, and the pitch routinely invokes intravenous silibinin for death-cap poisoning. That use is genuine, but it is a different molecular form, a different route, and a different mechanism — the capsule cannot borrow its credit.
The mechanism, in brief
Mechanism done; now the human results. One thing to stress: this is not a case of insufficient evidence, so let's wait. The trials that needed doing were done, and they were negative.
Sources (4)
- Rambaldi, A., Jacobs, B. P., & Gluud, C. (2007). Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database of Systematic Reviews, (4), CD003620. No significant effect on mortality or complications of liver disease.
- Fried, M. W., Navarro, V. J., Afdhal, N., Belle, S. H., Wahed, A. S., Hawke, R. L., et al. (2012). Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA, 308(3), 274-282. SyNCH trial, N=154, silymarin 420 or 700 mg three times daily × 24 weeks vs placebo: no significant difference in decline of serum ALT and no difference in HCV RNA — higher-than-customary doses did not help.
- Wah Kheong, C., Nik Mustapha, N. R., & Mahadeva, S. (2017). A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology, 15(12), 1940-1949.e8. N=99, silymarin 700 mg three times daily × 48 weeks: the primary histological endpoint (≥30% reduction in NAFLD activity score without worsening fibrosis) was not met; a reduction in fibrosis score was a secondary finding.
- National Center for Complementary and Integrative Health. (2025). Milk Thistle: Usefulness and Safety. Trial results for liver disease have been 'conflicting or too limited to allow conclusions'; two NCCIH-funded trials (hepatitis C and nonalcoholic steatohepatitis) showed no benefit. Allergic reactions can occur in people allergic to ragweed, chrysanthemum, marigold, and daisy.